200 related articles for article (PubMed ID: 31430592)
1. Serum B-Cell Maturation Antigen (BCMA) Levels Differentiate Primary Antibody Deficiencies.
Maglione PJ; Ko HM; Tokuyama M; Gyimesi G; Soof C; Li M; Sanchez E; Chen H; Radigan L; Berenson J; Cunningham-Rundles C
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):283-291.e1. PubMed ID: 31430592
[TBL] [Abstract][Full Text] [Related]
2. Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D; Dziedzic R; Drynda A; Gradzikiewicz A; Jakieła B; Celińska-Löwenhoff M; Padjas A; Matyja-Bednarczyk A; Zaręba L; Bazan-Socha S
Front Immunol; 2023; 14():1275892. PubMed ID: 37901210
[TBL] [Abstract][Full Text] [Related]
3. Factors Beyond Lack of Antibody Govern Pulmonary Complications in Primary Antibody Deficiency.
Weinberger T; Fuleihan R; Cunningham-Rundles C; Maglione PJ
J Clin Immunol; 2019 May; 39(4):440-447. PubMed ID: 31089938
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pulmonary diseases in common variable immunodeficiency and X-linked agammaglobulinaemia.
Aghamohammadi A; Allahverdi A; Abolhassani H; Moazzami K; Alizadeh H; Gharagozlou M; Kalantari N; Sajedi V; Shafiei A; Parvaneh N; Mohammadpour M; Karimi N; Sadaghiani MS; Rezaei N
Respirology; 2010 Feb; 15(2):289-95. PubMed ID: 20051045
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Bone Mineral Density in Common Variable Immunodeficiency and X-Linked Agammaglobulinaemia Patients.
Mohebbi A; Azizi G; Tavakolinia N; Abbasi F; Sayarifard F; Karimipour M; Kiaee F; Yazdani R; Ebrahimi SS; Ebrahimi M; Rafiemanesh H; Tafaroji J; Ziaee V; Abolhassani H; Aghamohammadi A
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):134-140. PubMed ID: 28606051
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID).
Bayrakci B; Ersoy F; Sanal O; Kiliç S; Metin A; Tezcan I
Turk J Pediatr; 2005; 47(3):239-46. PubMed ID: 16250308
[TBL] [Abstract][Full Text] [Related]
7. Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma.
Wiedemann Á; Szita VR; Horváth R; Szederjesi A; Sebő A; Tóth AD; Masszi T; Varga G
Pathol Oncol Res; 2023; 29():1611171. PubMed ID: 37188125
[No Abstract] [Full Text] [Related]
8. A Novel Point-of-Care Rapid Diagnostic Test for Screening Individuals for Antibody Deficiencies.
Israeli S; Golden A; Atalig M; Mekki N; Rais A; Storey H; Barbouche MR; Peck R
J Clin Immunol; 2022 Feb; 42(2):394-403. PubMed ID: 34839430
[TBL] [Abstract][Full Text] [Related]
9. Immunological and clinical features of pediatric patients with primary hypogammaglobulinemia in Taiwan.
Wang LJ; Yang YH; Lin YT; Chiang BL
Asian Pac J Allergy Immunol; 2004 Mar; 22(1):25-31. PubMed ID: 15366655
[TBL] [Abstract][Full Text] [Related]
10. Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.
Edwards ESJ; Bosco JJ; Aui PM; Stirling RG; Cameron PU; Chatelier J; Hore-Lacy F; O'Hehir RE; van Zelm MC
Front Immunol; 2019; 10():2593. PubMed ID: 31803177
[No Abstract] [Full Text] [Related]
11. Baseline serum B-cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.
Bujarski S; Goldwater MS; Regidor BS; Jew S; Daniely D; Swift RA; Eades BM; Emamy-Sadr M; Souther E; Li M; Wang C; Xu N; Chen H; Spektor TM; Berenson JR
Eur J Haematol; 2021 Sep; 107(3):318-323. PubMed ID: 33993536
[TBL] [Abstract][Full Text] [Related]
12. Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum.
Shin JJ; Liauw D; Siddiqui S; Lee J; Chung EJ; Steele R; Hsu FI; Price C; Kang I
J Clin Immunol; 2020 May; 40(4):592-601. PubMed ID: 32239366
[TBL] [Abstract][Full Text] [Related]
13. Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.
Viti R; Marcellusi A; Capone A; Matucci A; Vultaggio A; Pignata C; Spadaro G; Vacca A; Marasco C; Agostini C; Mennini FS
Clin Drug Investig; 2018 Oct; 38(10):955-965. PubMed ID: 30191508
[TBL] [Abstract][Full Text] [Related]
14. Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.
Slade CA; Bosco JJ; Binh Giang T; Kruse E; Stirling RG; Cameron PU; Hore-Lacy F; Sutherland MF; Barnes SL; Holdsworth S; Ojaimi S; Unglik GA; De Luca J; Patel M; McComish J; Spriggs K; Tran Y; Auyeung P; Nicholls K; O'Hehir RE; Hodgkin PD; Douglass JA; Bryant VL; van Zelm MC
Front Immunol; 2018; 9():694. PubMed ID: 29867917
[TBL] [Abstract][Full Text] [Related]
15. Primary Antibody Deficiency in a Tertiary Referral Hospital: A 30-Year Experiment.
Mohammadinejad P; Pourhamdi S; Abolhassani H; Mirminachi B; Havaei A; Masoom SN; Sadeghi B; Ghajar A; Afarideh M; Parvaneh N; Mirsaeed-Ghazi B; Movahedi M; Gharagozlou M; Chavoushzadeh Z; Mahdaviani A; Zandieh F; Sherkat R; Sadeghi-Shabestari M; Faridhosseini R; Jabbari-Azad F; Ahanchian H; Zandkarimi M; Cherghi T; Fayezi A; Mohammadzadeh I; Amin R; Aleyasin S; Moghtaderi M; Ghaffari J; Bemanian M; Shafiei A; Kalantari N; Ahmadiafshar A; Khazaei HA; Mohammadi J; Nabavi M; Rezaei N; Aghamohammadi A
J Investig Allergol Clin Immunol; 2015; 25(6):416-25. PubMed ID: 26817138
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity.
van Leeuwen LPM; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk F; van Gorp ECM; de Wilt F; Bogers S; Gommers L; Geers D; Bruns AHW; Leavis HL; van Haga JW; Lemkes BA; van der Veen A; de Kruijf-Bazen SFJ; van Paassen P; de Leeuw K; van de Ven AAJM; Verbeek-Menken PH; van Wengen A; Arend SM; Ruten-Budde AJ; van der Ent MW; van Hagen PM; Sanders RW; Grobben M; van der Straten K; Burger JA; Poniman M; Nierkens S; van Gils MJ; de Vries RD; Dalm VASH
J Allergy Clin Immunol; 2022 Jun; 149(6):1949-1957. PubMed ID: 35421449
[TBL] [Abstract][Full Text] [Related]
17. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
Ameratunga R; Ahn Y; Steele R; Woon ST
Front Immunol; 2019; 10():1541. PubMed ID: 31379811
[No Abstract] [Full Text] [Related]
18. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies.
Blanco E; Pérez-Andrés M; Arriba-Méndez S; Serrano C; Criado I; Del Pino-Molina L; Silva S; Madruga I; Bakardjieva M; Martins C; Serra-Caetano A; Romero A; Contreras-Sanfeliciano T; Bonroy C; Sala F; Martín A; Bastida JM; Lorente F; Prieto C; Dávila I; Marcos M; Kalina T; Vlkova M; Chovancova Z; Cordeiro AI; Philippé J; Haerynck F; López-Granados E; Sousa AE; van der Burg M; van Dongen JJM; Orfao A;
J Allergy Clin Immunol; 2019 Sep; 144(3):809-824. PubMed ID: 30826363
[TBL] [Abstract][Full Text] [Related]
19. [The expression level of secretory mature B cell surface antigen in primary diagnosed multiple myeloma and its clinical significance].
Yan Z; Chen GH; Yao WQ; Yan LZ; Jin S; Shang JJ; Shi XL; Wu DP; Fu CC
Zhonghua Yi Xue Za Zhi; 2022 Aug; 102(30):2351-2356. PubMed ID: 35970793
[No Abstract] [Full Text] [Related]
20. Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET).
Syed MN; Kutac C; Miller JM; Marsh R; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Kheradmand F; Hajjar J
J Clin Immunol; 2022 Oct; 42(7):1545-1552. PubMed ID: 35779201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
